T1	Participants 52 123	children with acute lymphoblastic leukemia in first bone marrow relapse
T2	Participants 186 230	relapsed acute lymphoblastic leukemia (ALL).
T3	Participants 241 287	patients with ALL in first bone marrow relapse
